← All tickers

Is ANNX Worth Buying in 2026?

Annexon, Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-04-19

Here’s whether Annexon, Inc. Common Stock (ANNX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); strong 1-year return of +357.3%; 3-month momentum positive (+7.7%). Concerns: 50-day MA is falling (-1.52% over 10 days); RSI 79 — overbought, elevated pullback risk. Currently 8.9% off its 52-week high. Score: +3/7.

Ready to act on this? 📈 Trade on Webull

ANNX is in a confirmed uptrend, trading above both its 50-day ($5.50) and 200-day ($4.08) moving averages. With an RSI of 78.5, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +357.3% compares to +35.1% for SPY (beat the market by 322.3%).

$10,000 invested 1 year ago → $45,734 today
vs. S&P 500 (SPY) — same period beat market by 322.3%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($4.08)
✓Above 50-day MA ($5.50)
!RSI(14) neutral zone (30–70) — currently 78.5
✓Positive return (+357.3%)
✓Within 10% of period high (−8.9%)
Period Range $6.54
$1.40 $7.18
RSI (14) 78.5
0 · OversoldOverbought · 100

Key Metrics

Price$6.54
Period Return+357.3%
Period High$7.18
Period Low$1.40
Drawdown−8.9%
MA-50$5.50
MA-200$4.08
RSI (14)78.5
Avg Volume (30d)2.7M
vs. SPYbeat by 322.3%
Return Rank#41 of 996

Trade ANNX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers